top of page
FDA approval for new therapy for the treatment of RDEB
Developed by Abeona Therapeutics, ZEVASKYN™ is the first and only is the first gene therapy to treat Recessive Dystrophic EB
Welcome to DEBRA International! The world's leading EB patient advocacy and support network.
bottom of page